Patents by Inventor Lisa Zawacki

Lisa Zawacki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
    Publication number: 20070054919
    Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.
    Type: Application
    Filed: February 14, 2006
    Publication date: March 8, 2007
    Inventors: Stuart Rosenblum, Seong Kim, Qingbei Zeng, Michael Wong, Gopinadhan Anilkumar, Yueheng Jiang, Wensheng Yu, Joseph Kozlowski, Neng-Yang Shih, Bandarpalle Shankar, Brian McGuinness, Guizhen Dong, Lisa Zawacki, Douglas Hobbs, John Baldwin, Yuefei Shao
  • Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
    Publication number: 20070021611
    Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.
    Type: Application
    Filed: February 14, 2006
    Publication date: January 25, 2007
    Inventors: Brian McGuinness, Stuart Rosenblum, Joseph Kozlowski, Gopinadhan Anilkumar, Seong Kim, Neng-Yang Shih, Chung-Her Jenh, Paul Zavodny, Douglas Hobbs, Guizhen Dong, Yuefei Shao, Lisa Zawacki, Cangming Yang, Carolyn Carroll